Dror Marchaim

1.3k total citations
22 papers, 807 citations indexed

About

Dror Marchaim is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Dror Marchaim has authored 22 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in Applied Microbiology and Biotechnology. Recurrent topics in Dror Marchaim's work include Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Nosocomial Infections in ICU (5 papers). Dror Marchaim is often cited by papers focused on Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Nosocomial Infections in ICU (5 papers). Dror Marchaim collaborates with scholars based in United States, Israel and Canada. Dror Marchaim's co-authors include Keith S. Kaye, Teena Chopra, Jason M. Pogue, Paul Lephart, Jack D. Sobel, Victoria J. Yee, Jingjing Zhao, Jaewon Lee, Suchitha Bheemreddy and Jing Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of the American Geriatrics Society.

In The Last Decade

Dror Marchaim

22 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dror Marchaim United States 13 340 301 229 227 127 22 807
Michael D. Nailor United States 19 489 1.4× 233 0.8× 177 0.8× 247 1.1× 191 1.5× 62 956
Sungmin Kiem South Korea 16 359 1.1× 250 0.8× 327 1.4× 314 1.4× 112 0.9× 29 838
Aleksandra Wierzbowski Canada 18 578 1.7× 425 1.4× 271 1.2× 282 1.2× 170 1.3× 31 1.1k
Juan García-de-Lomas Spain 13 667 2.0× 161 0.5× 200 0.9× 242 1.1× 137 1.1× 17 886
Rupali Jain United States 17 419 1.2× 335 1.1× 322 1.4× 412 1.8× 144 1.1× 55 1.1k
A. Carbonne France 17 342 1.0× 412 1.4× 106 0.5× 330 1.5× 220 1.7× 37 1.0k
Melinda K. Lacy United States 12 422 1.2× 316 1.0× 537 2.3× 219 1.0× 170 1.3× 21 1.0k
Georgios Daikos Greece 15 311 0.9× 338 1.1× 120 0.5× 301 1.3× 156 1.2× 32 928
Grace C. Lee United States 17 328 1.0× 271 0.9× 152 0.7× 339 1.5× 201 1.6× 41 1.1k
Vanthida Huang United States 15 170 0.5× 177 0.6× 239 1.0× 325 1.4× 73 0.6× 34 702

Countries citing papers authored by Dror Marchaim

Since Specialization
Citations

This map shows the geographic impact of Dror Marchaim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Marchaim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Marchaim more than expected).

Fields of papers citing papers by Dror Marchaim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dror Marchaim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Marchaim. The network helps show where Dror Marchaim may publish in the future.

Co-authorship network of co-authors of Dror Marchaim

This figure shows the co-authorship network connecting the top 25 collaborators of Dror Marchaim. A scholar is included among the top collaborators of Dror Marchaim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dror Marchaim. Dror Marchaim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Najjar‐Debbiny, Ronza, Bibiana Chazan, M. Todd Greene, et al.. (2022). Healthcare-associated infection prevention and control practices in Israel: results of a national survey. BMC Infectious Diseases. 22(1). 739–739. 4 indexed citations
2.
Youngster, Ilan, et al.. (2019). Potential Impact of Removing Metronidazole from Treatment Armamentarium of Mild Acute Clostridioides Difficile Infection. Future Microbiology. 14(17). 1489–1495. 7 indexed citations
3.
Viau, Roberto, Barry N Kreiswirth, Mark D. Adams, et al.. (2017). A Comparison of Molecular Typing Methods Applied to Enterobacter cloacae complex: hsp60 Sequencing, Rep-PCR, and MLST. SHILAP Revista de lepidopterología. 2(1). 23–23. 8 indexed citations
4.
Mayers, Douglas L., Jack D. Sobel, Marc Ouellette, Keith S. Kaye, & Dror Marchaim. (2017). Antimicrobial Drug Resistance. DIAL (Catholic University of Leuven). 17 indexed citations
5.
Lazarovitch, Tsilia, et al.. (2017). The MDR Upon Admission Score: Shortening Time to Initiation of Appropriate Antimicrobial Therapy in the Era of Resistance in the Community. Open Forum Infectious Diseases. 4(suppl_1). S138–S138. 1 indexed citations
6.
Chopra, Teena, Suchitha Bheemreddy, Christopher M. Saddler, et al.. (2016). Predictors of Clostridium difficile infection–related mortality among older adults. American Journal of Infection Control. 44(11). 1219–1223. 5 indexed citations
7.
Chopra, Teena, Dror Marchaim, Miriam Levine, et al.. (2015). Risk factors and acute in-hospital costs for infected pressure ulcers among gunshot-spinal cord injury victims in southeastern Michigan. American Journal of Infection Control. 44(3). 315–319. 8 indexed citations
8.
Chopra, Teena, Dror Marchaim, Paul C. Johnson, et al.. (2015). Risk factors for bloodstream infection caused by extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime. American Journal of Infection Control. 43(7). 719–723. 34 indexed citations
9.
Pogue, Jason M., Ryan P. Mynatt, Dror Marchaim, et al.. (2013). Automated Alerts Coupled with Antimicrobial Stewardship Intervention Lead to Decreases in Length of Stay in Patients with Gram-Negative Bacteremia. Infection Control and Hospital Epidemiology. 35(2). 132–138. 47 indexed citations
10.
Hayakawa, Kayoko, Dror Marchaim, Jason M. Pogue, et al.. (2012). Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: A case-case-control study. American Journal of Infection Control. 40(10). e261–e263. 14 indexed citations
11.
Marchaim, Dror, Bharath Sunkara, Paul Lephart, et al.. (2012). Extended-Spectrum β-Lactamase Producers Reported as Susceptible to Piperacillin-Tazobactam, Cefepime, and Cefuroxime in the Era of Lowered Breakpoints and No Confirmatory Tests. Infection Control and Hospital Epidemiology. 33(8). 853–855. 19 indexed citations
12.
Marchaim, Dror, et al.. (2012). Fluconazole-Resistant Candida albicans Vulvovaginitis. Obstetrics and Gynecology. 120(6). 1407–1414. 155 indexed citations
13.
Chopra, Teena, Dror Marchaim, Chris Kosmidis, et al.. (2012). Epidemiology and outcomes associated with surgical site infection following bariatric surgery. American Journal of Infection Control. 40(9). 815–819. 28 indexed citations
14.
Cook, Evelyn, Dror Marchaim, & Keith S. Kaye. (2011). Building a Successful Infection Prevention Program: Key Components, Processes, and Economics. Infectious Disease Clinics of North America. 25(1). 1–19. 16 indexed citations
15.
Kaye, Keith S., Dror Marchaim, Ting‐Yi Chen, et al.. (2011). Predictors of Nosocomial Bloodstream Infections in Older Adults. Journal of the American Geriatrics Society. 59(4). 622–627. 45 indexed citations
16.
Pogue, Jason M., Jaewon Lee, Dror Marchaim, et al.. (2011). Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System. Clinical Infectious Diseases. 53(9). 879–884. 279 indexed citations
17.
Dhar, Sorabh, Ryan Tansek, Margaret E. Flanagan, et al.. (2010). Observer Bias in Hand Hygiene Compliance Reporting. Infection Control and Hospital Epidemiology. 31(8). 869–870. 46 indexed citations
18.
Marchaim, Dror, Shai Efrati, Rimma Melamed, et al.. (2006). Clonal variability of group B Streptococcus among different groups of carriers in southern Israel. European Journal of Clinical Microbiology & Infectious Diseases. 25(7). 443–448. 9 indexed citations
19.
Bisharat, Naiel, Nicola Jones, Dror Marchaim, et al.. (2005). Population structure of group B streptococcus from a low-incidence region for invasive neonatal disease. Microbiology. 151(6). 1875–1881. 41 indexed citations
20.
Marchaim, Dror, Mordechai Hallak, Limor Gortzak‐Uzan, et al.. (2003). Risk factors for carriage of group B streptococcus in southern Israel.. PubMed. 5(9). 646–8. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael D. Nailor Breakdown of academic impact, for papers by Sungmin Kiem Breakdown of academic impact, for papers by Aleksandra Wierzbowski Breakdown of academic impact, for papers by Juan García-de-Lomas Breakdown of academic impact, for papers by Rupali Jain Breakdown of academic impact, for papers by A. Carbonne Breakdown of academic impact, for papers by Melinda K. Lacy Breakdown of academic impact, for papers by Georgios Daikos Breakdown of academic impact, for papers by Grace C. Lee Breakdown of academic impact, for papers by Vanthida Huang
Rankless by CCL
2026